丨证券研究报告丨 请阅读最后评级说明和重要声明 行业研究丨点评报告丨软件与服务 [Table_Title] Neuralink 发布重大突破，关注脑机接口迭代进 展 %% %% 报告要点 %% %% [Table_Summary] 当地时间 6 月 27 日，马斯克旗下脑机接口公司 Neuralink 发布了一段长达一小时的视频，展示 了他们最新的研究成果及产品发展方向。此次，作为世界领先的脑机接口企业，Neuralink 试验 的实际进展展示了脑机接口的可能性，其未来规划有望明确产业发展方向，并加速脑机接口大 规模商业化落地进度。建议关注三条主线：1、侵入式脑机接口海外先进产业链的国内映射标 的；2、非侵入式脑机接口在消费场景的产品落地相关标的；3、脑机接口下游应用端相关标的。 分析师及联系人 [Table_Author] 宗建树 SAC：S0490520030004 SFC：BUX668 1 软件与服务 cjzqdt11111 [Table_Title Neuralink 发布重大突破，关注脑机接口迭代进 2] 展 [Table_Summary2] 事件描述 当地时间 6 月 27 日，马斯克旗下脑机接口 ...

以下文章来源于创业板观察 ，作者宋子乔 创业板观察 . 创业板观察致力于发布深交所创业板的市场发展、政策变化、监管导向、上市企业动态等的及时信息， 提供有价值的市场资讯。 当地时间6月27日，马斯克带领Neuralink 脑机接口团队举行了一场持续1小时的发布会，展 示了最新进展以及三年路线图。 据介绍，目前Neuralink的受试者已经达到7人， 其中涵盖4名脊髓损伤患者与3名肌萎缩侧索 硬化症（ALS）患者，受试者们平均每周使用设备时长约50小时，峰值超100小时，几乎只要 是清醒的时间都在用。 通过Neuralink的"心灵感应"（Telepathy）产品，他们能够通过脑信号控制玩《马里奥赛 车》《使命召唤》等游戏，甚至用意念操控机械臂写字，与外界重新建立交互。 Neuralink目前已形成三大产品线（如下），受试者使用时长延长是脑机接口技术从实验室概 念迈向临床实用化的关键跨越。 心灵感应（Telepathy）： 针对运动障碍患者，64通道设备已实现意念操控电子设 备与机械臂，Alex案例中展现的特斯拉机械手协同操控，标志着其技术已触及神经 假肢的实用化临界点； 2026年：将电极通道/数量增加到30 ...

Core Insights - Neuralink, co-founded by Elon Musk, has completed a new funding round raising up to $600 million, with a pre-funding valuation of $9 billion [1] - The company aims to develop brain-machine interface (BMI) technology to treat neurological disorders and enhance human capabilities [3] Funding and Valuation - Neuralink's recent funding round aimed to raise at least $500 million from global institutional investors [1] - The company previously completed a $280 million Series D funding round in August 2023 [1] Technology and Development - Neuralink's core technology involves implanting wireless chips in the human skull to connect with the brain, enabling patients with conditions like paralysis and ALS to control devices using their thoughts [1] - The upgraded BMI chip, "Blindsight," is expected to be implanted in human patients by the end of 2025, with initial trials involving 20 to 30 patients [2] - The first human brain implant occurred in January 2024, marking a significant step towards allowing thought-based control of devices [2] Vision and Goals - Neuralink aims to treat various neurological diseases, including Parkinson's and Alzheimer's, while also striving for seamless integration between human cognition and artificial intelligence [3] - The company utilizes advanced, flexible, high-density electrodes and automated surgical robots to simplify the implantation process [3] - Neuralink's vision extends beyond medical applications, seeking to enhance human cognitive and physical abilities and integrate human consciousness with AI [3]